Loading…
Based on limited metadata, Wong Lap Kwong Medicine Company Limited received an FDA Warning Letter on January 11, 2018, regarding an unspecified product category classified as "Other." Without access to the full letter text or specific subject line, the exact nature of the violations cannot be determined from the available information. The issuing office is also unknown, which limits clarity on the specific regulatory pathway or product category involved. Additional documentation would be needed to identify the particular compliance issues cited by the FDA.